{
    "clinical_study": {
        "@rank": "48513", 
        "arm_group": [
            {
                "arm_group_label": "aPC treatment group", 
                "description": "Septic patients with at least two sepsis-induced organ failures occurring within 48 hours of the onset of sepsis treated with activated protein C at 24 mcg/Kg/h for 96 hours"
            }, 
            {
                "arm_group_label": "Control group", 
                "description": "Septic patients with at least two sepsis-induced organ failures occurring within 48 hours of the onset of sepsis not treated with activated protein C because of contraindications"
            }
        ], 
        "brief_summary": {
            "textblock": "Objective: to test the hypothesis that recombinant activated protein C (aPC) therapy\n      improves the microcirculation of severe septic patients.\n\n      Design: Prospective, open study. Setting: University 12-beds intensive care unit. Patients:\n      Septic patients with at least two sepsis-induced organ failures occurring within 48 hours of\n      the onset of sepsis were included in a one  year period.\n\n      Interventions: Patients who had no contraindication to aPC administration received aPC at a\n      dose of 24 mcg/kg/h for 96 hours. Patients with contraindications to aPC infusion were\n      considered as controls."
        }, 
        "brief_title": "Activated Protein C and Microcirculation", 
        "completion_date": {
            "#text": "August 2011", 
            "@type": "Actual"
        }, 
        "condition": [
            "Severe Sepsis", 
            "Septic Shock"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Sepsis", 
                "Toxemia", 
                "Shock", 
                "Shock, Septic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Septic patients with at least two sepsis-induced organ failures occurring within 48\n             hours of the onset of sepsis\n\n        Exclusion Criteria:\n\n          -  hematologic or advanced malignancies\n\n          -  liver cirrhosis\n\n          -  severely impaired consciousness (Glasgow Coma Scale score <7 of 15)\n\n          -  therapeutic limitations (do-not-resuscitate orders)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Septic patients with at least two sepsis-induced organ failures occurring within 48 hours\n        of the onset of sepsis"
            }
        }, 
        "enrollment": {
            "#text": "22", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01806428", 
            "org_study_id": "208249"
        }, 
        "intervention_browse": {
            "mesh_term": "Protein C"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 20, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Torrette di Ancona", 
                    "country": "Italy", 
                    "state": "Ancona", 
                    "zip": "60126"
                }, 
                "name": "University ICU, AOU Ospedali Riuniti Ancona"
            }
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_groups": "2", 
        "official_title": "THE Activated Protein C (aPC) TREATMENT IMPROVES MICROCIRCULATION IN SEVERE SEPSIS/ SEPTIC SHOCK SYNDROME", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2010", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Microcirculatory Flow Index detected in vivo by side-dark field imaging at sublingual microcirculation. It represents the quality of blood flow at microcirculatory level. This study wants to verify any of the considered different types of blood transfused can improve MFI.", 
            "measure": "Microcirculatory Flow Index (MFI) before during and after aPC infusion", 
            "safety_issue": "No", 
            "time_frame": "102 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01806428"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Universit\u00e0 Politecnica delle Marche", 
            "investigator_full_name": "Abele Donati, MD", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "results_reference": {
            "PMID": "24070065", 
            "citation": "Donati A, Damiani E, Botticelli L, Adrario E, Lombrano MR, Domizi R, Marini B, Van Teeffelen JW, Carletti P, Girardis M, Pelaia P, Ince C. The aPC treatment improves microcirculation in severe sepsis/septic shock syndrome. BMC Anesthesiol. 2013 Sep 26;13(1):25. [Epub ahead of print]"
        }, 
        "secondary_outcome": [
            {
                "description": "Perfused Vessel Density (PVD) detected in vivo by side-dark field imaging at sublingual microcirculation. It represents the quantity of well perfused vessels at microcirculatory level. This study wants to verify any of the considered different types of blood transfused can improve PVD.", 
                "measure": "Perfused Vessel Density before during and after aPC infusion", 
                "safety_issue": "No", 
                "time_frame": "102 hours"
            }, 
            {
                "description": "StO2 upslope is measured with Near InfraRed Spectroscopy at the tenar muscle. It represents the velocity of the recovery of the tissue oxygen saturation after a short period of ischemia of the hand, the Vascular Occlusion Test.", 
                "measure": "Tissue oxygen saturation (StO2) upslope before during and after aPC infusion", 
                "safety_issue": "No", 
                "time_frame": "102 hours"
            }
        ], 
        "source": "Universit\u00e0 Politecnica delle Marche", 
        "sponsors": {
            "collaborator": {
                "agency": "Azienda Ospedaliero-Universitaria Ospedali Riuniti Ancona", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Universit\u00e0 Politecnica delle Marche", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2009", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "October 2013"
    }
}